Tag Archives: immunotherapy

FDA Approves Keytruda Based on Cancer Genetics

The first-ever approval focuses on tumor genetics rather than tumor location
Posted on July 5, 2017 by Marissa Abruzzini (Blog Writer, SevenPonds)

For decades, cancer treatments focused on where tumors originated to determine how to treat the disease. But now for the first time, the FDA has approved the immunotherapy drug Keytruda to treat cancers based on genetic biomarkers rather than the location of the … Continue reading →

Posted in Something Special | Tagged , , , , , , , , , , , | Leave a comment

Immunotherapy: The Newfound Hope for Ovarian and Other Cancers

Immunotherapy offers hope to those with a life-threatening illness
Posted on April 12, 2017 by Kristen Capano (Blog Writer, SevenPonds)

Approximately 22,000 women will be diagnosed with ovarian cancer this year, resulting in over 14,000 deaths. This makes it the leading cause of death from gynecologic cancers in the United States. Also known as “the cancer that whispers,” ovarian cancer … Continue reading →

Posted in Something Special | Tagged , , , , , , , , , , , | 2 Comments

Immunotherapy drug Keytruda Tops Chemo in Lung Cancer Study

FDA may offer the drug to more patients based on promising results
Posted on June 22, 2016 by Ellary Allis (Blog Writer, SevenPonds)

Researches have stopped a study of Keytruda (pembrolizumab) the immunotherapy drug that former president Jimmy Carter says helped stop the progression of his advanced melanoma, because the medication is so effective that they want to offer it to all the patients in … Continue reading →

Posted in Something Special | Tagged , , , , , , , , , , , , | 2 Comments